News
-
2007-10-22 SpineVision Launches Two Of Its Latest Innovations At Europe’s Largest Spine Meeting EuroSpine 2007
-
2007-10-22 Ambrilia Dépose Un Prospectus Définitif Pour Un Placement De 15,6 Millions $
-
2007-10-22 Diatos Announces The Successful Completion Of Phase I Trial For DTS-201
-
2007-10-18 Paion Sees Continued Development Rationale For Desmoteplase Based On Findings From Phase III Analysis
-
2007-10-17 Diatos Announces Start Of The Preclinical Toxicology Program Of DTS-108
-
2007-10-17 20/10 Perfect Vision AG Closes EUR 13,5 Million Financing Round
-
2007-10-12 OctoPlus Announces Positive Phase IIA Efficacy And Tolerability Results For Locteron In Hepatitis C
-
2007-10-09 Traqueur Partenaire De Cofiparc Dans Son Offre Radicalement Innovante De Facturation Au Kilomètre
-
2007-10-09 Arpida Presents Additional Data On Iclaprim At IDSA
-
2007-09-30 20/10 Perfect Vision Converted Into A Stock Corporation